Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
IDH1 | 10 | 0 | 0 | 10 |
chromobox protein homolog 1 | 15 | 0 | 0 | 15 |
geminin | 28 | 0 | 0 | 28 |
hypoxia-inducible factor 1 alpha subunit | 10 | 0 | 0 | 10 |
RAR-related orphan receptor gamma | 19 | 0 | 0 | 19 |
GLI family zinc finger 3 | 25 | 0 | 0 | 25 |
AR protein | 33 | 0 | 0 | 33 |
aldehyde dehydrogenase 1 family, member A1 | 15 | 0 | 0 | 15 |
retinoic acid nuclear receptor alpha variant 1 | 19 | 0 | 0 | 19 |
retinoid X nuclear receptor alpha | 17 | 0 | 0 | 17 |
estrogen nuclear receptor alpha | 30 | 0 | 0 | 30 |
peroxisome proliferator-activated receptor delta | 11 | 0 | 0 | 11 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 16 | 0 | 0 | 16 |
activating transcription factor 6 | 9 | 0 | 0 | 9 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 10 | 0 | 0 | 10 |
Histone H2A.x | 6 | 0 | 0 | 6 |
thyroid hormone receptor beta isoform a | 7 | 0 | 0 | 7 |
heat shock protein beta-1 | 10 | 0 | 0 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 19 | 0 | 0 | 19 |
lamin isoform A-delta10 | 25 | 0 | 0 | 25 |
Voltage-dependent calcium channel gamma-2 subunit | 12 | 0 | 0 | 12 |
Glutamate receptor 2 | 12 | 0 | 0 | 12 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 5 | 1 | 6 |
5-hydroxytryptamine receptor 1A | 0 | 4 | 3 | 8 |
Sodium-dependent noradrenaline transporter | 0 | 7 | 0 | 7 |
Sodium-dependent dopamine transporter | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
Sodium-dependent serotonin transporter | 0 | 7 | 1 | 8 |
Sodium-dependent serotonin transporter | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 8 | 0 | 0 | 8 |
Chain B, HADH2 protein | 8 | 0 | 0 | 8 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 9 | 0 | 0 | 9 |
Thymidine kinase | 0 | 1 | 0 | 1 |
thioredoxin reductase | 12 | 0 | 0 | 12 |
phosphopantetheinyl transferase | 8 | 0 | 0 | 8 |
GLS protein | 8 | 0 | 0 | 8 |
TDP1 protein | 20 | 0 | 0 | 20 |
Smad3 | 7 | 0 | 0 | 7 |
thyroid stimulating hormone receptor | 14 | 0 | 0 | 14 |
EWS/FLI fusion protein | 9 | 0 | 0 | 9 |
arylsulfatase A | 6 | 0 | 0 | 6 |
euchromatic histone-lysine N-methyltransferase 2 | 24 | 0 | 0 | 24 |
Bloom syndrome protein isoform 1 | 9 | 0 | 0 | 9 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 4 | 0 | 0 | 4 |
Solute carrier family 22 member 1 | 0 | 4 | 0 | 7 |
ATP-binding cassette sub-family C member 3 | 0 | 20 | 0 | 20 |
Multidrug resistance-associated protein 4 | 0 | 20 | 0 | 20 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 6 | 0 | 6 |
Bile salt export pump | 0 | 30 | 0 | 30 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 10 | 0 | 11 |
Cytochrome P450 2J2 | 0 | 8 | 0 | 8 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 19 | 0 | 19 |
Thymidine kinase | 0 | 1 | 0 | 1 |
glucocorticoid receptor [Homo sapiens] | 23 | 0 | 0 | 23 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 11 | 0 | 0 | 11 |
Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
Corticosteroid-binding globulin | 0 | 4 | 0 | 4 |
Mineralocorticoid receptor | 0 | 3 | 3 | 6 |
Androgen receptor | 0 | 7 | 0 | 7 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 2 |
Guanine nucleotide-binding protein G | 5 | 0 | 0 | 5 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
regulator of G-protein signaling 4 | 7 | 0 | 0 | 7 |
Beta-1 adrenergic receptor | 0 | 1 | 2 | 4 |
D(1A) dopamine receptor | 6 | 0 | 0 | 6 |
DNA polymerase iota isoform a (long) | 10 | 0 | 0 | 10 |
Gamma-aminobutyric acid receptor subunit pi | 13 | 7 | 3 | 23 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Urease | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 4 | 2 | 6 |
Beta-1 adrenergic receptor | 0 | 4 | 2 | 6 |
Beta-3 adrenergic receptor | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit delta | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 13 | 7 | 3 | 23 |
Alpha-1D adrenergic receptor | 0 | 6 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 13 | 7 | 3 | 23 |
Alpha-1A adrenergic receptor | 0 | 2 | 2 | 5 |
Alpha-1B adrenergic receptor | 0 | 1 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit beta-3 | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit beta-2 | 13 | 7 | 3 | 23 |
TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
Beta-2 adrenergic receptor | 0 | 1 | 2 | 5 |
GABA theta subunit | 13 | 7 | 3 | 23 |
Gamma-aminobutyric acid receptor subunit epsilon | 13 | 7 | 3 | 23 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
NPYLR7B | 0 | 0 | 1 | 1 |
Amine oxidase [flavin-containing] A | 0 | 0 | 1 | 1 |
Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 1 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
nuclear receptor subfamily 1, group I, member 3 | 15 | 0 | 0 | 15 |
pregnane X nuclear receptor | 22 | 0 | 0 | 22 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 10 | 0 | 10 |
Muscarinic acetylcholine receptor M2 | 0 | 7 | 2 | 13 |
Muscarinic acetylcholine receptor M4 | 0 | 6 | 1 | 10 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 6 | 1 | 10 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 7 | 2 | 13 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 7 | 2 | 12 |
5-hydroxytryptamine receptor 2C | 0 | 10 | 1 | 11 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 9 | 0 | 1 | 12 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
pregnane X receptor | 7 | 0 | 0 | 7 |
progesterone receptor | 18 | 0 | 0 | 18 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 18 | 0 | 0 | 18 |
estrogen-related nuclear receptor alpha | 21 | 0 | 0 | 21 |
farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 11 | 0 | 0 | 11 |
aryl hydrocarbon receptor | 11 | 0 | 0 | 11 |
nuclear receptor subfamily 1, group I, member 2 | 8 | 0 | 0 | 8 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 11 | 1 | 17 |
Glycine receptor subunit alpha-1 | 0 | 10 | 0 | 10 |
Glycine receptor subunit beta | 0 | 10 | 0 | 10 |
Glycine receptor subunit alpha-2 | 0 | 10 | 0 | 10 |
Glycine receptor subunit alpha-3 | 0 | 10 | 0 | 10 |
ORF73 | 0 | 0 | 1 | 1 |
SMAD family member 2 | 6 | 0 | 0 | 6 |
SMAD family member 3 | 6 | 0 | 0 | 6 |
G | 12 | 0 | 0 | 12 |
cytochrome P450 2D6 | 11 | 0 | 0 | 11 |
peroxisome proliferator activated receptor gamma | 12 | 0 | 0 | 12 |
thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
thyroid hormone receptor beta isoform 2 | 19 | 0 | 0 | 19 |
Interferon beta | 15 | 0 | 0 | 15 |
HLA class I histocompatibility antigen, B alpha chain | 12 | 0 | 0 | 12 |
Inositol hexakisphosphate kinase 1 | 12 | 0 | 0 | 12 |
cytochrome P450 2C9, partial | 12 | 0 | 0 | 12 |
Cellular tumor antigen p53 | 19 | 0 | 0 | 19 |
Nuclear receptor ROR-gamma | 7 | 0 | 0 | 7 |
Potassium channel subfamily K member 3 | 0 | 3 | 0 | 3 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 2 | 3 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 13 | 0 | 0 | 13 |
Chain A, Cruzipain | 3 | 0 | 0 | 3 |
cytochrome P450 2C9 precursor | 7 | 0 | 0 | 7 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
Cytochrome P450 1A2 | 0 | 3 | 0 | 3 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 9 | 0 | 9 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 1 | 0 | 3 |
DNA gyrase subunit B | 0 | 1 | 0 | 3 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 3 | 0 | 3 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 4 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 8 | 0 | 9 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 11 | 0 | 0 | 11 |
glp-1 receptor, partial | 6 | 0 | 0 | 6 |
Fumarate hydratase | 6 | 0 | 0 | 6 |
Microtubule-associated protein tau | 8 | 0 | 0 | 9 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 9 | 0 | 0 | 9 |
estrogen receptor 2 (ER beta) | 11 | 0 | 0 | 11 |
nonstructural protein 1 | 5 | 0 | 0 | 5 |
polyprotein | 6 | 0 | 0 | 6 |
nuclear receptor ROR-gamma isoform 1 | 11 | 0 | 0 | 11 |
survival motor neuron protein isoform d | 8 | 0 | 0 | 8 |
neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
Luciferase | 9 | 0 | 0 | 9 |
interleukin 8 | 6 | 0 | 0 | 6 |
endonuclease IV | 5 | 0 | 0 | 5 |
PAX8 | 0 | 0 | 0 | 1 |
ATAD5 protein, partial | 9 | 0 | 0 | 9 |
USP1 protein, partial | 12 | 0 | 0 | 12 |
PPM1D protein | 1 | 0 | 0 | 1 |
Thrombopoietin | 3 | 0 | 0 | 3 |
67.9K protein | 7 | 0 | 0 | 7 |
glucocerebrosidase | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 isoform 1 | 6 | 0 | 0 | 6 |
nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
cellular tumor antigen p53 isoform a | 5 | 0 | 0 | 5 |
cytochrome P450 2C19 precursor | 6 | 0 | 0 | 6 |
atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 4 | 0 | 0 | 4 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
steroidogenic factor 1 | 0 | 1 | 0 | 1 |
peripheral myelin protein 22 | 8 | 0 | 0 | 8 |
cytochrome P450 3A4 isoform 1 | 13 | 0 | 0 | 13 |
muscleblind-like protein 1 isoform 1 | 7 | 0 | 0 | 7 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 10 | 0 | 0 | 10 |
lethal factor (plasmid) | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 3 |
Tubulin alpha-1A chain | 0 | 2 | 1 | 3 |
Tubulin beta chain | 0 | 2 | 1 | 3 |
Plasma kallikrein | 0 | 0 | 0 | 2 |
Tubulin beta-4A chain | 0 | 2 | 2 | 5 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Tubulin beta chain | 0 | 2 | 2 | 5 |
ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 6 |
Tubulin alpha-3C chain | 0 | 2 | 2 | 5 |
Serine/threonine-protein kinase pim-1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Tubulin alpha-1B chain | 0 | 2 | 2 | 5 |
Tubulin alpha-4A chain | 0 | 2 | 2 | 5 |
Tubulin beta-4B chain | 0 | 2 | 2 | 5 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Tubulin beta-3 chain | 0 | 2 | 2 | 5 |
Tubulin beta-2A chain | 0 | 2 | 2 | 5 |
Tubulin polymerization-promoting protein | 0 | 0 | 1 | 1 |
Tubulin beta-8 chain | 0 | 2 | 2 | 5 |
Tubulin beta-2B chain | 0 | 2 | 0 | 2 |
Tubulin alpha-3E chain | 0 | 2 | 2 | 5 |
Tubulin alpha-1A chain | 0 | 2 | 2 | 5 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
CREB-binding protein | 1 | 0 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 10 | 0 | 0 | 10 |
Ataxin-2 | 12 | 0 | 0 | 12 |
Tubulin alpha-1C chain | 0 | 2 | 2 | 5 |
Tubulin beta-6 chain | 0 | 2 | 2 | 5 |
Tubulin beta-2B chain | 0 | 2 | 2 | 5 |
Tubulin beta-1 chain | 0 | 2 | 2 | 5 |
6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase | 0 | 1 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 4 | 0 | 5 |
5-hydroxytryptamine receptor 6 | 0 | 5 | 1 | 6 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-2A adrenergic receptor | 0 | 4 | 3 | 8 |
Alpha-1B adrenergic receptor | 0 | 6 | 1 | 7 |
Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-2C adrenergic receptor | 0 | 4 | 3 | 8 |
Alpha-2B adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2C adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-1A adrenergic receptor | 0 | 6 | 1 | 7 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 5 |
Transthyretin | 0 | 0 | 1 | 3 |
Albumin | 0 | 2 | 2 | 4 |
Prostaglandin G/H synthase 1 | 0 | 2 | 1 | 3 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 5 |
UDP-glucuronosyltransferase 1-6 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A1 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 3 | 0 | 3 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 7 | 0 | 0 | 7 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
huntingtin isoform 2 | 3 | 0 | 0 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 6 | 1 | 7 |
Histamine H1 receptor | 0 | 1 | 3 | 5 |
Histamine H1 receptor | 0 | 4 | 2 | 6 |
5-hydroxytryptamine receptor 2B | 0 | 6 | 1 | 7 |
Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
Protein orai-2 | 0 | 1 | 0 | 1 |
Protein orai-3 | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 2 | 2 | 4 |
Histamine H3 receptor | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
Estrogen receptor | 0 | 4 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
Alpha-synuclein | 1 | 1 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 4 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 4 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 2 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 2 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
acetylcholinesterase | 3 | 0 | 0 | 3 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 4 | 0 | 0 | 4 |
mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
Cocaine esterase | 0 | 1 | 0 | 2 |
Androgen receptor | 0 | 4 | 0 | 4 |
Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
Spike glycoprotein | 11 | 0 | 0 | 11 |
Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa] | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
alpha synuclein, partial | 1 | 0 | 0 | 1 |
hypothetical protein, conserved | 3 | 0 | 0 | 3 |
luciferase | 1 | 0 | 0 | 1 |
caspase-3 | 4 | 0 | 0 | 4 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 5 | 0 | 0 | 5 |
Caspase-7 | 4 | 0 | 0 | 4 |
tumor necrosis factor | 2 | 0 | 0 | 2 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
caspase-3 | 4 | 0 | 0 | 4 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Integrin beta-3 | 2 | 0 | 0 | 2 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 2 | 0 | 0 | 2 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 5 | 1 | 6 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 4 | 1 | 5 |
Alpha-2B adrenergic receptor | 0 | 2 | 1 | 4 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 3 | 1 | 4 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 1 | 1 | 0 | 0 | 1 |
Histamine H2 receptor | 0 | 3 | 2 | 5 |
Adenosine receptor A2a | 0 | 4 | 1 | 5 |
Mu-type opioid receptor | 0 | 3 | 1 | 4 |
D(3) dopamine receptor | 0 | 3 | 0 | 3 |
Kappa-type opioid receptor | 0 | 3 | 1 | 4 |
Glutamate receptor ionotropic, kainate 2 | 1 | 0 | 0 | 1 |
Glutamate receptor ionotropic, kainate 3 | 1 | 0 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 1 | 2 | 0 | 3 |
Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
Glutamate receptor ionotropic, kainate 4 | 1 | 0 | 0 | 1 |
Leukotriene B4 receptor 1 | 1 | 0 | 0 | 2 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 1 | 0 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 1 | 0 | 0 | 2 |
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 6 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
GALC protein | 3 | 0 | 0 | 3 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
Adenosine receptor A1 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 2 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 2 | 1 | 3 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 3 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 3 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 2 | 3 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
Cytochrome P450 144 | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 3 |
Cholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Type-1A angiotensin II receptor | 0 | 1 | 0 | 1 |
Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
Transporter | 0 | 2 | 0 | 2 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
plasminogen precursor | 3 | 0 | 0 | 3 |
urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
Progesterone receptor | 0 | 2 | 1 | 4 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 3 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
NFKB1 protein, partial | 4 | 0 | 0 | 4 |
Parkin | 2 | 0 | 0 | 2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
perilipin-5 | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Nrf2 | 1 | 0 | 0 | 1 |
Microphthalmia-associated transcription factor | 0 | 0 | 0 | 1 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
caspase recruitment domain family, member 15 | 0 | 1 | 0 | 1 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
receptor-interacting serine/threonine-protein kinase 2 isoform 1 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
Type II pantothenate kinase | 0 | 0 | 0 | 1 |
Type III pantothenate kinase | 0 | 0 | 0 | 1 |
dopamine D1 receptor | 2 | 0 | 0 | 2 |
vasopressin V1b receptor | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Tumor necrosis factor | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chitotriosidase-1 | 0 | 2 | 1 | 3 |
Endochitinase B1 | 0 | 2 | 1 | 3 |
Estrogen receptor 1 | 0 | 1 | 0 | 1 |
fMet-Leu-Phe receptor | 0 | 1 | 0 | 1 |
Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Delta-type opioid receptor | 0 | 1 | 1 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Chain A, Bacterial regulatory proteins, tetR family | 0 | 0 | 1 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 3 |
Tyrosinase | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Sphingosine kinase 2 | 0 | 2 | 0 | 2 |
Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
ATP-dependent 6-phosphofructokinase | 0 | 1 | 0 | 1 |
Dihydropteroate synthase | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
Protease | 0 | 1 | 1 | 2 |
Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate Reductase | 0 | 0 | 1 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, dihydrofolate reductase (DHFR) | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase type 1 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase type 1 from Tn4003 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Trace amine-associated receptor 5 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |